Browse > Article

Socioeconomic Costs of Stroke in Korea: Estimated from the Korea National Health Insurance Claims Database  

Lim, Seung-Ji (Department of Public Health, Yonsei University Graduate School)
Kim, Han-Joong (Department of Preventive Medicine and Public Health, Yonsei University College of Medicine)
Nam, Chung-Mo (Department of Preventive Medicine and Public Health, Yonsei University College of Medicine)
Chang, Hoo-Sun (Graduate School of Public Health, Yonsei University)
Jang, Young-Hwa (Department of Public Health, Yonsei University Graduate School)
Kim, Se-Ra (Health Insurance Review and Assessment Service)
Kang, Hye-Young (Graduate School of Public Health, Yonsei University)
Publication Information
Journal of Preventive Medicine and Public Health / v.42, no.4, 2009 , pp. 251-260 More about this Journal
Abstract
Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients and caregivers productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.
Keywords
Cost of illness; Costs; Illness burden; Prevention; Stroke;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By SCOPUS : 10
연도 인용수 순위
1 Korea National Statistical Office. Report on Death Causes 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
2 Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27(13): 1610-1619   DOI   ScienceOn
3 Matchar DB, Duncan PW. Cost of stroke. Stroke Clin Updates 1994; 5(3): 9-12
4 Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke 1996; 27(9): 1459-1466   DOI   PUBMED   ScienceOn
5 Terent A, Marke LA, Asplund K, Norrving B, Jonsson E, Wester PO. Costs of stroke in Sweden: A national perspective. Stroke 1994; 25(12): 2363-2369   DOI   PUBMED   ScienceOn
6 Evers SM, Engel GL, Ament AJ. Cost of stroke in The Netherlands from a societal perspective. Stroke 1997; 28(7): 1375-1381   DOI   PUBMED   ScienceOn
7 Kang HY, Kim HJ, Park TK, Jee SH, Nam CM, Park HW. Economic burden of smoking in Korea. Tob Control 2003; 12(1): 37-44   DOI   ScienceOn
8 Korea Ministry of Labor. Statistics for Wage Structure 2005. Gwacheon: Korea Ministry of Labor; 2006. (Korean)
9 Korea National Statistical Office. Life time table. Daejeon: Korea National Statistical Office; [cited 2009 May 5]. Available from: URL:http: //kosis.nso.go.kr. (Korean)
10 Organization for Economic Co-operation and Development. OECD Health Data 2008: Statistics and Indicators for 30 Countries. Paris: Organization for Economic Co-operation and Development; 2008
11 Barrett-Connor E. The economic and human costs of osteoporotic fracture. Am J Med 1995; 98(2A): 3S-8S   DOI   PUBMED   ScienceOn
12 Kang S, Jeong J, Moon B, Kim J. Current epidemiological status of cerebrovascular disease. J Korean Neurosurg Soc 1999; 28(4): 509-513. (Korean)
13 Council of the European Union. 2586th Council Meeting-Employment, Social Policy, Health and Consumer Affairs. Brussels: Council of the European Union; 2004
14 Drummond M, O Brien B, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Program. New York: Oxford University Press; 1997
15 Kim SH, Lee YS, Lee SM, Yoon BW, Park BJ. Body mass index and risk of hemorrhagic stroke in Korean adults: Case-control study. J Prev Med Public Health 2007; 40(4): 313-320. (Korean)   DOI   ScienceOn
16 Bergman L, van der Meulen JH, Limburg M, Habbema JD. Costs of medical care after firstever stroke in The Netherlands. Stroke 1995; 26(10): 1830-1836   DOI   PUBMED   ScienceOn
17 Park C, Kang H, Kwon I, Kang D, Jung H. Cost-of-illness Study of asthma in Korea: Estimated from the Korea National Health Insurance Claims Database. J Prev Med Public Health 2006; 39(5): 397-403. (Korean)   PUBMED
18 Korea National Statistical Office. Age-andgender-specific Population Size 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
19 Matchar DB, Samsa GP, Liu S. Costeffectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty. Value Health 2005; 8(5): 572-580   DOI   ScienceOn
20 Arredondo A, Zuniga A. Epidemiologic changes and economic burden of hypertension in Latin America: Evidence from Mexico. Am J Hypertens 2006; 19(6): 553-559   DOI   ScienceOn
21 Yoneda Y, Okuda S, Hamada R, Toyota A, Gotoh J, Watanabe M, et al. Hospital cost of ischemic stroke and intracerebral hemorrhage in Japanese stroke centers. Health Policy 2005; 73(2): 202-211   DOI   ScienceOn
22 Feigin VL, Wiebers DO, Nikitin YP, O Fallon WM, Whisnant JP. Stroke epidemiology in Novosibirsk, Russia: A population-based study. Mayo Clin Proc 1995; 70(9): 847-852   DOI   ScienceOn
23 World Health Organization. World Health Report 2004. Geneva: World Health Organization; 2004
24 Chung YH, Ko SJ. Estimating socioeconomic costs of five major diseases. Korean J Public Finance 2004; 18(2): 77-104. (Korean)
25 Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care 2001; 39(6): 599-615   DOI   ScienceOn
26 National Health Insurance Corporation. 2005 Survey on National Health Insurance Patients Out-of-pocket Expenditure. Seoul: National Health Insurance Corporation; 2006. (Korean)
27 Lee KS, Bae HJ, Kim HS. Utilization of health care resources and costs of stroke patients: Patients perspective. J Korean Neurol Assoc 2004; 22(6): 583-589. (Korean)
28 Paul SL, Srikanth VK, Thrift AG. The large and growing burden of stroke. Curr Drug Targets 2007; 8(7): 786-793   DOI   ScienceOn
29 Korea National Statistical Office. Report on the Social Statistics Survey 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
30 Scott WG, Scott H. Ischaemic stroke in New Zealand: An economic study. N Z Med J 1994; 107(989): 443-446   PUBMED   ScienceOn
31 Rice D. Cost-of-illness studies: Fact or fiction. Lancet 1994; 344(8936): 1519-1520   DOI   ScienceOn
32 Chung W, Chun H, Lee S. Socioeconomic costs of alcohol drinking in Korea. J Prev Med Public Health 2006; 39(1): 21-29. (Korean)   과학기술학회마을
33 Isard PA, Forbes JF. The cost of stroke to the national health service in Scotland. Cerebrovasc Dis 1992; 2(1): 47-50   DOI
34 Dodel RC, Haacke C, Zamzow K, Paweilik S, Spottke A, Rethfeldt M, et al. Resource utilization and costs of stroke unit care in Germany. Value Health 2004; 7(2): 144-152   DOI   ScienceOn
35 Korea National Statistical Office. Yearbook of Labor Statistics 2005. Daejeon: Korea National Statistical Office; 2006. (Korean)
36 Persson U, Silverberg R, Lindgren B, Norrving B, Jadback G, Johansson B, et al. Direct costs of stroke for a Swedish population. Int J Technol Assess Health Care 1990; 6(1): 125-137   DOI   PUBMED
37 Rossnagel K, Nolte CH, Muller-Nordhorn J, Jungehulsing GJ, Selim D, Bruggenjurgen B, et al. Medical resource use and costs of health care after acute stroke in Germany. Eur J Neurol 2005; 12(11): 862-868   DOI   ScienceOn
38 Chang SM, Cho SJ, Jeon HJ, Hahm BJ, Lee HJ, Park JI, et al. Economic burden of schizophrenia in South Korea. J Korean Med Sci 2008; 23(2): 167-175. (Korean)   DOI   ScienceOn
39 Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M. The cost of cardiovascular diseases in the United Kingdom. Heart 2006; 92(10): 1384-1389   DOI   PUBMED   ScienceOn
40 Chan B, Hayes B. Cost of stroke in Ontario, 1994-1995. CMAJ 1998; 159(6 suppl): S2-S7